CLINICAL_TRIALS
withdrawal
· 2024-09-03
Clinical Trial Update: Hyperbaric Oxygen for Carbon Monoxide Induced Chronic Encephalopathy [NA]
Summary
This clinical trial update shows that the hyperbaric oxygen study for carbon monoxide–induced chronic encephalopathy has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Nebraska | Conditions: Carbon Monoxide Poisoning, Chronic Encephalopathy | NA | Status: WITHDRAWN